Proteomic approaches for drug discovery against tegumentary leishmaniasis

作者: Fernanda Negrão , Marcos Nogueira Eberlin , Selma Giorgio , None

DOI: 10.1016/J.BIOPHA.2017.08.089

关键词: LeishmaniasisDrug discoveryContext (language use)ImmunologyDrug developmentAmastigoteLeishmaniaProteomicsBiologyProteome

摘要: Abstract Tegumentary leishmaniases (TL) comprise various clinical forms, in which current therapeutic treatments lack safety and efficacy. Recently the parasite is developing resistance mechanisms against anti leishmanial drugs startling scientific community to recruit efforts search for novel therapeutics. Proteomics hold promises treatment of leishmaniasis investigation parasite–host interaction since these set methodological tools have provided a wealth protein expression data on several Leishmania species. Firstly this review puts together challenges fight tegumentary leishmaniasis. In addition, 2 dimensional gel electrophoresis mass spectrometry techniques identification characterization are described discussed context proteomics regarding studies. review, we selected literature content TL causative agents. Important proteomic findings related differentiation proteome (promastigote amastigote forms), -macrophage secreted soluble proteins including molecules involved potential drug targets examined discussed. We also highlight open questions research that can be addressed with approaches.

参考文章(57)
Ioan Lascu, Anna Giartosio, Stéphane Ransac, Muriel Erent, Quaternary structure of nucleoside diphosphate kinases. Journal of Bioenergetics and Biomembranes. ,vol. 32, pp. 227- 236 ,(2000) , 10.1023/A:1005580828141
Jose Batista de Jesus, Camila Mesquita-Rodrigues, Patricia Cuervo, Proteomics Advances in the Study of Leishmania Parasites and Leishmaniasis Subcellular Biochemistry. ,vol. 74, pp. 323- 349 ,(2014) , 10.1007/978-94-007-7305-9_14
Valdir Sabbaga Amato, Felipe Francisco Tuon, Hélio Arthur Bacha, Vicente Amato Neto, Antonio Carlos Nicodemo, Mucosal leishmaniasis . Current scenario and prospects for treatment. Acta Tropica. ,vol. 105, pp. 1- 9 ,(2008) , 10.1016/J.ACTATROPICA.2007.08.003
Douglas de Souza Moreira, Pascale Pescher, Christine Laurent, Pascal Lenormand, Gerald F. Späth, Silvane M. F. Murta, Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania braziliensis lines by 2D-DIGE technology Proteomics. ,vol. 15, pp. 2999- 3019 ,(2015) , 10.1002/PMIC.201400611
Rafael Góngora, Nathalie Acestor, Manfredo Quadroni, Nicolas Fasel, Nancy G. Saravia, John Walker, Mapping the proteome of Leishmania Viannia parasites using two-dimensional polyacrylamide gel electrophoresis and associated technologies. Biomedica. ,vol. 23, pp. 153- 160 ,(2003) , 10.7705/BIOMEDICA.V23I2.1207
Matthias Corrotte, Sylvette Chasserot-Golaz, Ping Huang, Guangwei Du, Nicholas T. Ktistakis, Michael A. Frohman, Nicolas Vitale, Marie-France Bader, Nancy J. Grant, Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis Traffic. ,vol. 7, pp. 365- 377 ,(2006) , 10.1111/J.1600-0854.2006.00389.X
R. Badaro, K. Weerasuriya, C. P. Thakur, L. Pang, K. Behbehani, F. Kuzoe, R. Davidson, J. D. Berman, A. D. M. Bryceson, K. M. Wasunna, Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bulletin of The World Health Organization. ,vol. 76, pp. 25- 32 ,(1998)
N G Saravia, M A Gemmell, S L Nance, N L Anderson, Two-dimensional electrophoresis used to differentiate the causal agents of American tegumentary leishmaniasis. Clinical Chemistry. ,vol. 30, pp. 2048- 2052 ,(1984) , 10.1093/CLINCHEM/30.12.2048
Simon L Croft, Shyam Sundar, Alan H Fairlamb, None, Drug Resistance in Leishmaniasis Clinical Microbiology Reviews. ,vol. 19, pp. 111- 126 ,(2006) , 10.1128/CMR.19.1.111-126.2006
Henriques C., Atella G., Bonilha V., W. de Souza, Biochemical analysis of proteins and lipids found in parasitophorous vacuoles containing Leishmania amazonensis. Parasitology Research. ,vol. 89, pp. 123- 133 ,(2003) , 10.1007/S00436-002-0728-Y